Most Active Stories
- Successful Entrepreneur Paul Cummings & Foundation Leader Cordell Carter Team Up to Launch TechTown
- City of Chattanooga Designates 140-Acre Downtown Area as 'Innovation District'
- Pentagon's Money-Saver: U.S. Troops To Leave 15 European Sites
- Start It Up Ep 10: Why a Good Bookkeeper Matters and Chattanooga's Filmmaking Community is on Fire
- Douglas Tallamy: Why Home Gardening 'Transcends the Needs of the Gardener'
STEVE INSKEEP, HOST:
NPR's business news starts with a big fine for Johnson & Johnson.
(SOUNDBITE OF MUSIC)
INSKEEP: So much for no more tears. A judge in Arkansas ordered the company most famous for its baby shampoo to by more than a billion dollars in fines yesterday over its marketing for a very different product. That would be an antipsychotic drug, Risperdal.
Experts say the $1.2 billion penalty is among the biggest on record for a state-level fraud case involving a pharmaceutical company. A jury found that Johnson & Johnson failed to properly disclose the drug's possible side effects, like weight gain, risk of strokes in older patients, and increased risk of diabetes.
Johnson & Johnson says there's no evidence patients were harmed, and is asking for a new trial. Transcript provided by NPR, Copyright National Public Radio.